Category
Linagliptin
CAS Number
668270-11-9
Molecular Formula
C₂₅H₂₈N₈O₂
Molecular Weight
472.54 g/mol
Synonym

8-[(3S)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione; ent-linagliptin; (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione; Linagliptin S-Isomer; S-Linagliptin; 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione

Keywords
Impurities
Heterocycles
Pharmaceutical Standards
Fine Chemicals
Intermediates
Aromatics
Impurities manufacturer and Suppliers in Hyderabad india
slide.1

Linagliptin EP Impurity A is a specified impurity associated with Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. It is a reference standard used in pharmaceutical quality control for the identification, detection, and quantification of impurities during the analysis of linagliptin drug substance and drug products, ensuring compliance with European Pharmacopoeia (EP) quality requirements.